Objective To describe clinical characteristics and immunotherapy responses in patients with
autoimmune epilepsy. Design Observational, retrospective case series. Setting Mayo Clinic …

Objective: To evaluate a trial of immunotherapy as an aid to diagnosis in suspected
autoimmune epilepsy. Method: We reviewed the charts of 110 patients seen at our …

Objective: We aimed to report the pattern of usage and efficacy of antiepileptic drugs (AEDs)
in patients with autoimmune epilepsy (AE). Methods: We retrospectively studied the Mayo …

Seizures are recognized as a common manifestation of autoimmune limbic encephalitis and
multifocal paraneoplastic disorders, but accumulating evidence supports an autoimmune …

Epilepsy may present as a symptom of many neurological disorders and often an
aetiological explanation cannot be identified. There is growing evidence that autoimmune …

There is emerging interest in autoimmune epilepsy, which represents a small but potentially
treatable form of epilepsy. Most insights into autoimmune epilepsy derive from the recent …

Seizures are a well‐recognized and often prominent manifestation of autoimmune
encephalitic syndromes. Progress in detection of pathogenic neural autoantibodies has led …

Objective To generate a score which clinically identifies surface-directed autoantibodies in
adults with new-onset focal epilepsy, and evaluate the value of immunotherapy in this …

An estimated 0.5–1% of the world population is epileptic, some with completely unknown
etiology and no effective treatment. Epilepsies have long been viewed as diseases of the …

There are a growing number of specific antibodies associated with new onset epilepsy.
These patients are likely to have an immune-mediated disorder that may benefit from …